Parallel trade of pharmaceutical products: the ECJ finally speaks— Comment on GlaxoSmithKline

Petrucci, Carlo 2010, 'Parallel trade of pharmaceutical products: the ECJ finally speaks— Comment on GlaxoSmithKline' , European Law Review (2) , pp. 275-286.

[img] PDF - Published Version
Restricted to Repository staff only

Download (322kB) | Request a copy


This article reviews the ECJ’s judgment in GlaxoSmithKline that overturned some important findings of the CFI’s decision. It criticises the longstanding problematic distinction between anti-competitive object and effect and, in particular, whether distribution agreements that limit parallel trade fit into the category of agreement having an anti-competitive object. Given that the ECJ’s decision reasserted a multi- goal approach to EU competition law, it is argued that the judgment leaves some issues unresolved. Similarly, the issues of the effects of price regulation and research and development (R&D) funding have not been dealt with adequately.

Item Type: Article
Themes: Subjects outside of the University Themes
Schools: Schools > Salford Business School > Business and Management Research Centre
Journal or Publication Title: European Law Review
Publisher: Sweet & Maxwell
Refereed: Yes
ISSN: 0307-5400
Depositing User: Mr Carlo Petrucci
Date Deposited: 15 Nov 2011 10:32
Last Modified: 29 Oct 2015 00:48

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)


Downloads per month over past year